Pelvic inflammatory disease: Clinical sciences

2,992views

Pelvic inflammatory disease: Clinical sciences

Women's Health - Midterm

Women's Health - Midterm

Cervical cancer
Breast cancer
Ovarian germ cell tumors
Endometrial hyperplasia
Uterine fibroid
Endometriosis
Amenorrhea: Pathology review
Breast cancer: Pathology review
Cervical cancer: Pathology review
Benign breast conditions: Pathology review
Sexually transmitted infections: Vaginitis and cervicitis: Pathology review
Uterine disorders: Pathology review
Vaginal and vulvar disorders: Pathology review
Ovarian cysts and tumors: Pathology review
Menstrual cycle
Estrogen and progesterone
Anatomy and physiology of the female reproductive system
Ectopic pregnancy
Miscarriage
Pelvic inflammatory disease
Ectopic pregnancy: Clinical sciences
Approach to acute pelvic pain (GYN): Clinical sciences
Well-patient care (GYN): Clinical sciences
Cervical cancer screening: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Emergency contraception: Clinical sciences
Reversible contraception: Clinical sciences
Permanent contraception (sterilization): Clinical sciences
Therapeutic and induced abortions: Clinical sciences
Endometriosis: Clinical sciences
Adnexal torsion: Clinical sciences
Pelvic inflammatory disease: Clinical sciences
Approach to a breast mass and asymmetry: Clinical sciences
Approach to nipple discharge: Clinical sciences
Approach to breast pain (mastalgia): Clinical sciences
Breast abscess: Clinical sciences
Breast papilloma: Clinical sciences
Fibroadenoma: Clinical sciences
Invasive lobular carcinoma: Clinical sciences
Lobular carcinoma in situ: Clinical sciences
Invasive ductal carcinoma: Clinical sciences
Fibrocystic breast changes: Clinical sciences
Breast cyst: Clinical sciences
Ductal carcinoma in situ: Clinical sciences
Approach to primary amenorrhea: Clinical sciences
Approach to secondary amenorrhea: Clinical sciences
Polycystic ovary syndrome (PCOS): Clinical sciences
Approach to postmenopausal bleeding: Clinical sciences
Cervical dysplasia and cervical cancer: Clinical sciences
Endometrial intraepithelial neoplasia (hyperplasia) and carcinoma: Clinical sciences
Adenomyosis: Clinical sciences
Uterine leiomyoma: Clinical sciences
Primary dysmenorrhea: Clinical sciences
Approach to adnexal masses: Clinical sciences

Decision-Making Tree

Questions

USMLE® Step 2 style questions USMLE

0 of 4 complete

Start
A 26-year-old woman presents to the emergency department for evaluation of pelvic pain. She has also had vaginal discharge and nausea and vomiting for the past 3 days. The patient has multiple sexual partners and uses barrier protection inconsistently. Temperature is 39°C (102.2°F), blood pressure is 130/60 mmHg, pulse is 90/min, respiratory rate is 16/min, and oxygen saturation is 98% on room air. Pelvic examination demonstrates cervical motion tenderness, bilateral adnexal tenderness, and a mucopurulent cervical discharge. Labs including wet mount and nucleic amplification testing for gonorrhea and chlamydia are pending. Urine beta HCG is negative. Transvaginal ultrasonography shows no abnormalities. Which of the following is the best next step in management?  

Transcript

Watch video only

Pelvic inflammatory disease, or PID for short, is an inflammatory condition that can affect the uterus, fallopian tubes, ovaries, and peritoneum. PID is often caused by infection with sexually transmitted organisms such as gonorrhea and chlamydia. However, it may also be caused by microorganisms normally found in the vaginal flora.

Inflammation of the fallopian tubes, also known as salpingitis, increases the risk of infertility and ectopic pregnancy, while peritonitis can lead to pelvic adhesions and chronic pelvic pain. Even very mild cases of PID can lead to these sequelae. Finally, based on the severity, the clinical presentation of PID can range from asymptomatic or only mild symptoms to severe pelvic pain or even sepsis.

Your first step in evaluating a patient presenting with a chief concern suggesting PID is to perform a CABCDE assessment in order to determine if they are stable or unstable, which in most cases would indicate they’ve developed sepsis.

If the patient is unstable, stabilize their airway, breathing, and circulation right away. This means that you might have to intubate the patient, obtain IV access and continuously monitor their vital signs. In addition, you should immediately obtain an HCG pregnancy test!

Once you have initiated acute management, your next step is to take a focused history and physical exam. Patients typically report fever, nausea and vomiting, lower abdominal and pelvic pain, abnormal vaginal discharge, and intermenstrual or post-coital spotting.

Here’s a high-yield fact! If this patient reports upper abdominal pain, you should consider perihepatitis, also known as Fitz-Hugh-Curtis syndrome. Perihepatitis develops when the pathogenic microorganisms causing PID spill from the fimbriae and settle in the space surrounding the liver and diaphragm. This leads to inflammation of the liver capsule, without involvement of the liver parenchyma, as well as to the formation of the so-called “violin string” adhesions between the liver and the peritoneum, resulting in right upper quadrant pain that can mimic gallbladder disease.

Okay, back to the physical exam. Here, you might find signs of sepsis, such as elevated temperature, hypotension, and tachycardia. Be sure to assess the abdomen for diffuse tenderness, which may include rebound pain or guarding. In addition, the pelvic exam may reveal signs of cervicitis, such as swelling, inflammation, and mucopurulent cervical discharge, as well as cervical motion tenderness, uterine and adnexal tenderness. Finally, you might find an adnexal mass, which should get you to think about a tubo-ovarian abscess.

Based on these findings, you should suspect PID with sepsis. If this is the case, initiate IV fluids and targeted IV antibiotics. In addition, obtain appropriate labs, including CBC, chemistries, and lactate to monitor your patient’s progression, as well as blood cultures and nucleic acid amplification testing, or NAAT, to identify the causative infections. Lastly, obtain a gynecologic surgery consultation for possible exploration.

Alright, now that unstable patients are taken care of, let’s talk about stable patients. Your first step in managing a stable patient is a focused history and physical exam as well as labs including microscopy of the vaginal discharge, an ESR, CRP, and a NAAT for gonorrhea and chlamydia.

Here’s another high-yield fact! Although many cases of PID are associated with gonorrhea and chlamydia, other organisms such as Trichomonas vaginalis, bacterial vaginosis, Mycoplasma genitalium, cytomegalovirus, and bacteria that comprise the normal vaginal flora can be involved. So, consider also obtaining a NAAT for these organisms.

Alright, the history might reveal systemic symptoms of fever, nausea, and vomiting. Additionally, as stated earlier, the patient may report lower abdominal and pelvic pain, dysuria, dyspareunia, abnormal vaginal discharge, and intermenstrual or post-coital spotting.

When obtaining the history, be sure to discuss sexual activity, particularly recent sexual activity or new partners, as well as douching. A private, confidential discussion is important for all patients, including young patients like adolescents. Although it may be difficult, you should ask caregivers of young patients to step out of the room for this discussion.

Additionally, always consider sexual assault or abuse whenever a young patient has a positive sexual activity history, especially if the patient is a child. If there is abuse going on, you will need to follow up with allegations of abuse in accordance with your State’s law.

Finally, review the patient's contraceptive history. Keep in mind that non-barrier methods of pregnancy prevention, such as oral contraceptive pills, do not prevent transmission of diseases such as gonorrhea or chlamydia.

Here is a high-yield fact! The presence of an intrauterine device, or IUD does not increase the risk of developing PID except within the first 3 weeks of insertion. Also, keep in mind that IUDs typically do not need to be removed while treating PID, unless treatment fails after 48 to 72 hours.

Sources

  1. "Sexually transmitted infections treatment guidelines, 2021" MMWR Recomm Rep (2021)
  2. "Pelvic Inflammatory Disease" Obstet Gynecol (2010)